ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Mixed Modality (Oligonucleotide) Advisor at Eli Lilly and Company - ApplyBlast

Mixed Modality (Oligonucleotide) Advisor

Eli Lilly and Company

1 month ago

4.0 on Glassdoor

Lebanon, Indiana, United States

Onsite

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Mixed Modality (Oligonucleotide) Advisor sets technical strategy and direction for oligonucleotide manufacturing process transfers from development laboratories to pilot plant operations. This role serves as the site's recognized technical authority on oligonucleotide process transfer, shaping the Lilly Medicine Foundry's approach to early-phase cGMP manufacturing. The position involves leading process improvement, ensuring plant readiness, and providing technical leadership across cross-functional teams.

Responsibilities

Set technical strategy for oligonucleotide process transfers across programs
Define scale-up approach for synthesis and purification methods
Serve as technical authority on oligonucleotide unit operations

Skills

Qualifications

B.S. in ChemistryM.S. in ChemistryPh.D. in ChemistryB.S. in BiochemistryM.S. in Biochemistry

About Eli Lilly and Company

lilly.com

Headquarters

Indianapolis, Indiana, United States

Company Size

10001+ employees

Founded

1876

View Profile

Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.